[1]
A. Upadhyay, S. Mahakalkar, and P. Tiple, “Comparative assessment of safety and efficacy of Vortioxetine with Escitalopram in patients with MDD (Major Depressive Disorder): a randomized, comparative, parallel group, open-label study”, Int J of Pharmc Res, vol. 12, no. 3, p. e5726, Mar. 2022, Accessed: Mar. 14, 2025. [Online]. Available: https://ssjournals.co.in/index.php/ijpr/article/view/5726